226 related articles for article (PubMed ID: 34794376)
1. Outcomes of endoscopic submucosal dissection for gastroesophageal reflux disease (ESD-G) for medication-refractory gastroesophageal reflux disease: 35 cases underwent ESD-G including 15 cases followed more than 5 years.
Ota K; Takeuchi T; Kojima Y; Sugawara N; Nishida S; Iwatsubo T; Kawaguchi S; Harada S; Tokioka S; Higuchi K
BMC Gastroenterol; 2021 Nov; 21(1):432. PubMed ID: 34794376
[TBL] [Abstract][Full Text] [Related]
2. A novel endoscopic submucosal dissection technique for proton pump inhibitor-refractory gastroesophageal reflux disease.
Ota K; Takeuchi T; Harada S; Edogawa S; Kojima Y; Inoue T; Higuchi K
Scand J Gastroenterol; 2014 Dec; 49(12):1409-13. PubMed ID: 25384555
[TBL] [Abstract][Full Text] [Related]
3. Frontiers in Endoscopic Treatment for Gastroesophageal Reflux Disease.
Ota K; Takeuchi T; Higuchi K; Sasaki S; Mori Y; Tanaka H; Hakoda A; Sugawara N; Iwatsubo T; Nishikawa H
Digestion; 2024; 105(1):5-10. PubMed ID: 37591209
[TBL] [Abstract][Full Text] [Related]
4. New treatment method for refractory gastroesophageal reflux disease (GERD): C-BLART (clip band ligation anti-reflux therapy)-a short-term study.
Liu S; Chai N; Zhai Y; Zou J; Feng X; Li Z; Li L; Zhang X; Wang X; Wang S; Linghu EQ
Surg Endosc; 2020 Oct; 34(10):4516-4524. PubMed ID: 31728750
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
[TBL] [Abstract][Full Text] [Related]
6. Use of an endoscopic suturing device (the "ESD") to treat patients with gastroesophageal reflux disease, after unsuccessful EndoCinch endoluminal gastroplication: another failure.
Schiefke I; Neumann S; Zabel-Langhennig A; Moessner J; Caca K
Endoscopy; 2005 Aug; 37(8):700-5. PubMed ID: 16032486
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
Takeuchi T; Oota K; Harada S; Edogawa S; Kojima Y; Sanomura M; Sakaguchi M; Hayashi K; Hongoh Y; Itabashi T; Kitae H; Hoshimoto M; Takeuchi N; Higuchi K
Intern Med; 2015; 54(2):97-105. PubMed ID: 25742999
[TBL] [Abstract][Full Text] [Related]
8. Pilot study on anti-reflux mucoplasty: Advancing endoscopic anti-reflux therapy for gastroesophageal reflux disease.
Inoue H; Yamamoto K; Shimamura Y; Azuma D; Ushikubo K; Okada H; Kimoto Y; Nishikawa Y; Tanaka I; Tanabe M; Onimaru M; Navarro MJ
Dig Endosc; 2024 Jun; 36(6):690-698. PubMed ID: 37899073
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: Experience of 109 cases.
Sumi K; Inoue H; Kobayashi Y; Iwaya Y; Abad MRA; Fujiyoshi Y; Shimamura Y; Ikeda H; Onimaru M
Dig Endosc; 2021 Mar; 33(3):347-354. PubMed ID: 32415898
[TBL] [Abstract][Full Text] [Related]
10. Lack of correlation between gastroesophageal reflux disease symptoms and esophageal lesions after sleeve gastrectomy.
Soricelli E; Casella G; Baglio G; Maselli R; Ernesti I; Genco A
Surg Obes Relat Dis; 2018 Jun; 14(6):751-756. PubMed ID: 29571635
[TBL] [Abstract][Full Text] [Related]
11. More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy.
Kusano M; Hosaka H; Kawamura O; Kawada A; Kuribayashi S; Shimoyama Y; Yasuoka H; Mizuide M; Tomizawa T; Sagawa T; Sato K; Yamada M
J Gastroenterol; 2015 Mar; 50(3):298-304. PubMed ID: 24919745
[TBL] [Abstract][Full Text] [Related]
12. Short and long term effect of anti-reflux mucosectomy with cap-assisted endoscopic mucosal resection for refractory gastroesophageal disease.
Lee YS; Kim JH; Yon DK; Yoo IK
Surg Endosc; 2024 Apr; 38(4):2180-2187. PubMed ID: 38448622
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux.
Akiyama J; Hosaka H; Kuribayashi S; Moriyasu S; Hisada Y; Okubo H; Watanabe K; Imbe K; Nagata N; Kojima Y; Yokoi C; Uemura N; Shimoyama Y; Kawamura O; Yamada M; Kusano M
Digestion; 2020; 101(2):174-183. PubMed ID: 30897577
[TBL] [Abstract][Full Text] [Related]
14. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
Azzam RS
Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
[TBL] [Abstract][Full Text] [Related]
15. [The role of the traditional surgical procedures for gastroesophageal reflux disease cannot be ignored].
Zhou JH; Tan QY
Zhonghua Wai Ke Za Zhi; 2020 Sep; 58(9):672-676. PubMed ID: 32878412
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic management of gastroesophageal reflux disease: Panacea for proton pump inhibitors dependent/refractory patients.
Kalapala R; Singla N; Reddy DN
Dig Endosc; 2022 May; 34(4):687-699. PubMed ID: 34651353
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic full-thickness plication for the treatment of PPI-dependent GERD: results from a randomised, sham controlled trial.
Kalapala R; Karyampudi A; Nabi Z; Darisetty S; Jagtap N; Ramchandani M; Gupta R; Lakhtakia S; Goud R; Venkat Rao G; Sharma P; Reddy DN
Gut; 2022 Apr; 71(4):686-694. PubMed ID: 33849942
[TBL] [Abstract][Full Text] [Related]
18. Gastroesophageal Reflux Disease: Pathophysiology and New Treatment Trends.
Kasugai K; Ogasawara N
Intern Med; 2024 Jan; 63(1):1-10. PubMed ID: 36927966
[TBL] [Abstract][Full Text] [Related]
19. The early therapeutic response at 2 weeks is a crucial predictor of proton pump inhibitor-refractory gastroesophageal reflux disease.
Ogawa M; Arihiro S; Matsuhashi N; Joh T; Higuchi K; Iwakiri K; Kamiya T; Manabe N; Isshi K; Nakada T; Hokari A; Saruta M; Oshio A; Haruma K; Nakada K
Esophagus; 2021 Apr; 18(2):398-406. PubMed ID: 33136239
[TBL] [Abstract][Full Text] [Related]
20. Esophageal mucosal breaks in gastroesophageal reflux disease partially responsive to proton pump inhibitor therapy.
Shaheen NJ; Denison H; Björck K; Silberg DG
Am J Gastroenterol; 2013 Apr; 108(4):529-34. PubMed ID: 23318482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
